Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2012
12/26/2012CN102838657A Human tumor marker TBRG4 (transforming growth factor beta regulator 4) polypeptide and application thereof
12/26/2012CN102225966B Method for solid phase peptide synthesis
12/26/2012CN101568550B Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
12/26/2012CN101407541B Modified allosteric type cyclic citrulline polypeptide, and fusion protein, antibody and reagent kit thereof
12/26/2012CN101372511B Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/25/2012US8338380 Use of the peptide RFMWMR as a therapeutic agent
12/25/2012US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
12/25/2012US8338364 Peptide tyrosinase inhibitors and uses thereof
12/20/2012WO2012173942A2 Organic syringomycin methods and compositions
12/20/2012WO2012173762A1 Cyclic lactadherin peptide mimetics and their uses
12/20/2012WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals
12/20/2012WO2012173222A1 Gallium-labeled drug
12/20/2012WO2012172887A1 Therapeutic agent for heart diseases and cell sheet for treating heart diseases
12/20/2012WO2011110716A3 Peptide compounds that can be used as antibacterial agents
12/20/2012US20120322852 SMNdelta7 Degron: Novel Compositions and Methods of Use
12/20/2012US20120322748 Novel peptides that enhance tight junction permeability
12/20/2012US20120322740 Mu opioid receptor agonist analogs of the endomorphins
12/20/2012US20120322724 Molecules for targeting compounds to various selected organs or tissues
12/20/2012US20120321701 Ang-(1-7) receptor agonist
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321652 Peptides for active anti-cytokine immunization
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321649 Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens
12/20/2012US20120321636 Antibodies specific for sclerostin and methods for increasing bone mineralization
12/20/2012DE102011118029A1 Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung Modified antibiotic peptides with variable systemic release
12/19/2012CN102834409A Cyclosporine analogues
12/19/2012CN102834408A Aromatic-cationic peptides and uses of same
12/19/2012CN102827277A Anti-human serum albumin single-chain antibody and method for connecting polypeptide drugs to carbon end thereof
12/19/2012CN102827255A Antibacterial peptide GW13 and its preparation method and use
12/19/2012CN102827254A Cell penetrating peptide hPP10 and use thereof
12/19/2012CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof
12/19/2012CN102827252A One kind of magnetic resonance imaging developers and two-photon imaging developers and preparation method thereof
12/19/2012CN102827251A Transmembrane peptide-mediated antisense antibacterial agent and preparation method and application thereof
12/19/2012CN102827250A Fatty acid-modificatory amphiphilic cation self-assembling peptide and application thereof
12/19/2012CN102827249A Liquid-phase synthetic method of eptifibatide
12/19/2012CN102212110B Beta-lactamase inhibitory peptide and application thereof
12/18/2012US8334364 High-molecular weight derivative of nucleic acid antimetabolite
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8334255 Peptide and treatment for HIV-1 infection
12/18/2012US8334253 Cosmetic and dermatological formulations of MNTF peptides
12/18/2012CA2385122C Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
12/15/2012CA2766417A1 Stabilized therapeutic small helical antiviral peptides
12/13/2012WO2012171020A1 Protein-polymer-drug conjugates
12/13/2012WO2012170842A2 Peptide for protection of allergic respiratory disorders
12/13/2012WO2012170804A1 Treatments for gastrointestinal disorders
12/13/2012WO2012170084A1 Composition and method for treating lung disease and mucous cell metaplasia
12/13/2012WO2012168944A1 Therapeutic compounds for immunomodulation
12/13/2012WO2012168820A1 Polymyxin derivatives useful as antibacterial agents
12/13/2012WO2012168486A1 Cetp fragments
12/13/2012WO2012168336A1 Beta - hairpin peptidomimetics as cxc4 antagonists
12/13/2012WO2012167588A1 Amino acid sequence of affinity peptide of bone marrow mesenchymal stem cells, screening methods and the use thereof.
12/13/2012WO2012167587A1 Synovial mesenchymal stem cell affinitive polypeptide, screening method and use thereof
12/13/2012WO2012126118A8 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
12/13/2012WO2012118353A3 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
12/13/2012US20120316318 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
12/13/2012US20120316120 Fluorine containing compounds and methods of use thereof
12/13/2012US20120316118 Oligopeptide improving differentiation of osteoblasts
12/13/2012US20120316115 Methods and compositions for inhibiting angiogenesis
12/13/2012US20120316114 Variants of C-type Natriuretic Peptide
12/13/2012US20120316113 Fgf based fibrin binding peptides
12/13/2012US20120316105 Polymyxin Derivates Useful As Antibacterial Agents
12/13/2012US20120316104 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
12/13/2012US20120316103 Cyclic antimicrobial peptides
12/13/2012US20120316101 Peptides for targeting apoptotic cells and uses thereof
12/13/2012US20120315701 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same
12/13/2012US20120315256 Use of transforming growth factor - beta 1 (tgf-b1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
12/13/2012US20120315220 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
12/13/2012DE102011118030A1 Herstellung und Verwendung eines Peptids mit einer N-terminalen 11C-markierten Acetylgruppe Preparation and Use of a peptide having an N-terminal 11C-labeled acetyl group
12/13/2012CA2838833A1 Pro-coagulant compounds and methods of use thereof
12/13/2012CA2838037A1 Beta-hairpin peptidomimetics as cxc4 antagonists
12/13/2012CA2837840A1 Protein-polymer-drug conjugates
12/13/2012CA2837767A1 Cetp fragments
12/12/2012EP2532359A1 CETP fragments
12/12/2012EP2531520A1 Template-fixed peptidomimetics with cxcr7 modulating activity
12/12/2012EP2531519A1 Lantibiotic salts
12/12/2012EP2531518A1 Oligopeptidic compounds and uses thereof
12/12/2012EP2531517A2 Caspase-14 activator peptides and compositions comprising said peptides
12/12/2012EP2531205A1 Actagardine derivatives, and pharmaceutical use thereof
12/12/2012EP2531204A1 Template - fixed peptidomimetics with cxcr7 modulating activity
12/12/2012CN102822194A Treatments for gastrointestinal disorders
12/12/2012CN102822193A Modified MELK peptides and vaccines containing the same
12/12/2012CN102816212A Rubiaceae-type cyclopeptide, its pharmaceutical composition and application
12/12/2012CN102816211A Preparation method of melanotan-II
12/12/2012CN102816210A Secondary sicca syndrome epitope and application thereof
12/12/2012CN102816209A Chemokine-derived peptide, its expression gene and application thereof
12/12/2012CN102816208A Liquid phase synthesis method of bivalirudin
12/12/2012CN102816207A Method for purifying caspofungin precursor pneumocandin B0 component
12/12/2012CN102816206A Synthetic peptide and application thereof
12/12/2012CN102816205A Beta-profilin 1, and fragment and applications thereof
12/12/2012CN102156164B Mass spectra identification method of nucleophosmin variable spliceosome and gastric cancer diagnostic reagent kit
12/12/2012CN101659694B Anti-tumor cyclic pentapeptide compound and preparation method thereof
12/12/2012CN101305019B 新的环肽化合物 The new cyclic peptide compound
12/11/2012US8329865 Antimicrobially active peptides
12/11/2012US8329864 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
12/11/2012US8329862 Cell-killing peptide derived from the C-terminus of NOXA protein
12/11/2012US8329859 Peptides that home to tumor lymphatic vasculature and methods of using same
12/11/2012US8329640 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (VIP) and their use for the treatment of lung diseases
12/11/2012CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
12/11/2012CA2513104C Survivin-derived peptides and use thereof
12/11/2012CA2507524C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 423